Showing results (41-50 of 656) with videos related to

Sort By:
Pageof 66
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 30, 2014
Addressing current treatment challenges in Crohn's disease in real life: a physician's surveyStephan R Vavricka, Sanja Radivojevic, Christine N Manser, et al.
The American Journal of Gastroenterology|October 19, 2018
Malignancies in Inflammatory Bowel Disease: Frequency, Incidence and Risk Factors-Results from the Swiss IBD Cohort StudySylvie Scharl, Christiane Barthel, Jean-Benoit Rossel, et al.
Plos One|September 1, 2012
Fc gamma receptor CD64 modulates the inhibitory activity of infliximabKacper A Wojtal, Gerhard Rogler, Michael Scharl, et al.
United European Gastroenterology Journal|March 12, 2016
Alicaforsen, an antisense inhibitor of ICAM-1, as treatment for chronic refractory pouchitis after proctocolectomy: A case seriesThomas Greuter, Luc Biedermann, Gerhard Rogler, et al.
Inflammatory Intestinal Diseases|June 21, 2018
Risk Factors for the Development of Fistulae and Stenoses in Crohn Disease Patients in the Swiss Inflammatory Bowel Disease CohortJonas Zeitz, Nicolas Fournier, Christian Labenz, et al.
Frontiers in Gastroenterology (Lausanne, Switzerland)|July 1, 2026
Infliximab as ultima ratio in a case of refractory non-Crohn's disease complex fistula system: case report and mini-review of the literatureNada Agbariah, Matthias Kis, Christine Manser, et al.
Journal of Crohn'S & Colitis|April 5, 2018
Colectomy Rates in Ulcerative Colitis are Low and Decreasing: 10-year Follow-up Data From the Swiss IBD Cohort StudyLevente Parragi, N Fournier, Jonas Zeitz, et al.
Journal of Crohn'S & Colitis|August 31, 2018
Upper Gastrointestinal Tract Involvement in Crohn's Disease: Frequency, Risk Factors, and Disease CourseThomas Greuter, Alberto Piller, Nicolas Fournier, et al.
Pageof 66